NeuroOne Medical Technologies Corporation

NasdaqCM:NMTC Stok Raporu

Piyasa değeri: US$29.0m

NeuroOne Medical Technologies Yönetim

Yönetim kriter kontrolleri 3/4

NeuroOne Medical Technologies CEO'su Dave Rosa, Jul2017 tarihinde atandı, in görev süresi 7.33 yıldır. in toplam yıllık tazminatı $ 989.56K olup, şirket hissesi ve opsiyonları dahil olmak üzere 51.2% maaş ve 48.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.38% ine doğrudan sahiptir ve bu hisseler $ 400.07K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.7 yıl ve 6.7 yıldır.

Anahtar bilgiler

Dave Rosa

İcra Kurulu Başkanı

US$989.6k

Toplam tazminat

CEO maaş yüzdesi51.2%
CEO görev süresi7.3yrs
CEO sahipliği1.4%
Yönetim ortalama görev süresi4.7yrs
Yönetim Kurulu ortalama görev süresi6.7yrs

Son yönetim güncellemeleri

Recent updates

Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?

Dec 16
Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?

Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?

Jul 25
Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?

Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation

Apr 11
Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation

We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully

Sep 15
We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully

NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet

Aug 03

Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?

Jun 02
Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?

Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky

Dec 18
Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky

NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions

Nov 19

Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?

Sep 04
Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?

We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate

May 27
We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate

CEO Tazminat Analizi

Dave Rosa'un ücretlendirmesi NeuroOne Medical Technologies'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$12m

Mar 31 2024n/an/a

-US$13m

Dec 31 2023n/an/a

-US$13m

Sep 30 2023US$990kUS$507k

-US$12m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$9m

Dec 31 2022n/an/a

-US$9m

Sep 30 2022US$1mUS$472k

-US$10m

Jun 30 2022n/an/a

-US$11m

Mar 31 2022n/an/a

-US$11m

Dec 31 2021n/an/a

-US$11m

Sep 30 2021US$2mUS$411k

-US$10m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020n/an/a

-US$11m

Sep 30 2020US$1mUS$404k

-US$14m

Jun 30 2020n/an/a

-US$14m

Mar 31 2020n/an/a

-US$9m

Dec 31 2019n/an/a

-US$10m

Sep 30 2019US$558kUS$392k

-US$7m

Jun 30 2019n/an/a

-US$8m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018n/an/a

-US$6m

Sep 30 2018US$417kUS$288k

-US$7m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$496kUS$357k

-US$5m

Tazminat ve Piyasa: Dave 'nin toplam tazminatı ($USD 989.56K ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 655.65K ).

Tazminat ve Kazançlar: Dave 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Dave Rosa (60 yo)

7.3yrs

Görev süresi

US$989,558

Tazminat

Mr. David A. Rosa, also known as Dave, M.D., serves as an Independent Director of BioRestorative Therapies, Inc. since November 4, 2021. He serves as Director of BlinkTBI, Inc. since July 2023. He serves a...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
David Rosa
President7.3yrsUS$989.56k1.38%
$ 400.1k
Ronald McClurg
Chief Financial Officer3.8yrsUS$390.16k0.37%
$ 107.0k
Steven Mertens
Chief Technology Officer5.6yrsUS$457.71k0.16%
$ 46.2k
Mark Christianson
Co-Founderno dataUS$260.85k0.85%
$ 246.8k
Christopher Volker
Chief Operating Officerless than a yearVeri yok0.24%
$ 70.5k
Hijaz Haris
Vice President of Marketingno dataVeri yokVeri yok

4.7yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim: NMTC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
David Rosa
President7.3yrsUS$989.56k1.38%
$ 400.1k
Jeffrey Mathiesen
Independent Director7.3yrsUS$120.49k0.27%
$ 78.2k
Paul Buckman
Independent Chairman of the Board7.3yrsUS$168.99k0.35%
$ 102.5k
Edward Andrle
Independent Director4.8yrsUS$118.99k0.20%
$ 57.1k
Robert Gross
Member of Scientific Advisory Board3.4yrsVeri yokVeri yok
Greg Worrell
Chairman of Scientific Advisory Boardno dataVeri yokVeri yok
Jamie Van Gompel
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Gregory Esper
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Justin Williams
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Kip Ludwig
Member of Scientific Advisory Board6.2yrsVeri yokVeri yok

6.7yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NMTC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.7 yıldır).